Clinical Trial Update: StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for StrataGraft skin tissue used in complex skin defects across Phase 1 and Phase 2, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Degloving Injury
• Third-degree Burns
• Wound Infection

Drugs mentioned

• StrataGraft

Snippet

Sponsor: Stratatech, a Mallinckrodt Company | Conditions: Third Degree Burn, Burns | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-10